Background: Acute jaundice remains a critical problem following liver transplantation. MicroRNAs (miRNAs) are involved in regulating gene expression related to various disease phenotypes and statuses. Aims: To differentiate acute jaundice etiology after living donor liver transplantation (LDLT), we examined the hepatic miRNA expression patterns in several liver graft pathologies. Methods: Eighty liver transplant recipients undergoing post-LDLT graft biopsy for the evaluation of acute jaundice were enrolled in this 1-year prospective study. Using a real-time quantitative reverse transcription-polymerase chain reaction profiling assay, we identified hepatic miRNA (miRNA-122, miRNA-301, miRNA-133a, and miRNA-21) signatures in various allografts pathologies. Results: Pathologic findings of the 80 recipients were as follows: acute cholangitis (AC), 37 (46%); acute rejection (AR), 20 (25%); recurrent hepatitis (RH), 12 (15%); non-specific pathological change, 6 (8%); and fatty change (FC), 5 (6%). None of these identified hepatic miRNAs expression pattern was significantly correlated with serum parameters, including neutrophil-lymphocyte ratio. In AC, hepatic miRNA-122, miRNA-301, miRNA-133a, and miRNA-21 expression was significantly downregulated (p < 0.05). MicroRNA-122 expression was elevated in cases of AR and RH (p < 0.05); miRNA-301 and miRNA-21 expression was higher in RH than in AC (p < 0.05); and miRNA-133a expression was higher in FC than in AR (p < 0.05). Conclusions: Our study suggests that specific hepatic miRNA expression patterns as a checklist may be useful for differential diagnosis of acute jaundice following liver transplantation.

Surgery for acute mesenteric infarction (AMI) is associated with high mortality. This study aimed to generate a mortality prediction model to predict the 30-day mortality of surgery for AMI. We included patients ≥18 years who received bowel resection in treating AMI and randomly divided into the derivation and validation groups. After multivariable analysis, the ‘Surgery for acute mesenteric infarction mortality score’ (SAMIMS) system was generated and was including age >62-year-old (3 points), hemodialysis (2 points), congestive heart failure (1 point), peptic ulcer disease (1 point), diabetes (1 point), cerebrovascular disease (1 point), and severe liver disease (4 points). The 30-day-mortality rates in the derivation group were 4.4%, 13.4%, 24.5%, and 32.5% among very low (0 point), low (1–3 point(s)), intermediate (4–6 points), and high (7–13 points)-risk patients. Compared to the very-low-risk group, the low-risk (OR = 3.332), intermediate-risk (OR = 7.004), and high-risk groups (OR = 10.410, p < 0.001) exhibited higher odds of 30-day mortality. We identified similar results in the validation group. The areas under the ROC curve were 0.677 and 0.696 in the derivation and validation groups. Our prediction model, SAMIMS, allowed for the stratification of the patients’ 30-day-mortality risk of surgery for acute mesenteric infarction.

The major treatment for perforated peptic ulcers (PPU) is surgery, and several scoring systems have been reported to predict morbidity and mortality after surgery. However, it remains unclear which patient should receive nonoperative management instead of surgery. This study aimed to generate a scoring system for surgeons to identify patients with PPU who may be too weak to undergo surgery and without any survival benefit. We extracted the admission data of adult (≥ 18 years) patients with PPU disease from the NHIRD database. They were randomly divided into an 80% model derivation cohort and a 20% validation cohort. Multivariate analysis with a logistic regression model was applied to generate the scoring system, PPUMS. The scoring system was then applied to the validation group. The PPUMS score ranged from 0 to 8 points, composite with age (< 45: 0 points, 45–65: 1 point, 65–80: 2 points, > 80: 3 points), and five comorbidities (congestive heart failure, severe liver disease, renal disease, history of malignancy, and obesity: 1 point each). In the derivation group, patients with PPUMS > 4 had a 45.9% in-hospital mortality rate and similar in-hospital mortality risk in the operation group [traditional laparotomy: odds ratio (OR) = 0.729, p = 0.320, laparoscopy: OR = 0.772, p = 0.697] and the non-operation group. In the validation group, patients with PPUMS > 4 points had a 36.9% mortality rate and similar mortality risk in the operation group (traditional laparotomy: OR = 0.353, p = 0.093, laparoscopy: no applicable) and non-operation group. PPUMS is a good predictor of mortality risk in patients with PPU and with various underlying diseases or comorbidities. Surgical management is suggested for patients with PPU with PPUMS ≤ 4 points because of lower mortality risk. However, in patients with PPUMS > 4 points, surgery may have limited benefit due to the high mortality rate compared to nonoperative treatment.

Multiple studies have provided varied results on the relationship between gallbladder polyps (GBPs), fatty liver disease (FLD), and metabolic factors.The purpose of this study was to determine the possible risk factors related to GBP formation in Taiwanese population through the use of health examinations.In this retrospective study, 1311 subjects who underwent abdominal sonography for health evaluations from September 2019 to August 2020 were randomly enrolled. Baseline characteristics of the study subjects were recorded. Risk factors related to GBP formation were analyzed. All participants' series of abdominal sonography examinations in our hospital were also retrospectively reviewed to reveal the presence of GBPs through second-look sonography.Among 1311 participants, 946 participants (72.2%) had clinically evident FLD, as documented using abdominal sonography; GBPs were found in 233 (24.6%) subjects with FLD. The incidence of FLD was significantly associated with the presence of GBP (P < .001; OR: 4.16, 95%